SYNJ2BP Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to SYNJ2BP and Its Antibodies

SYNJ2BP (Synaptojanin 2 Binding Protein) is a protein that has gained significant attention in recent research. It is also known by alternative names including ARIP2, OMP25, and mitochondrial outer membrane protein 25 . SYNJ2BP is primarily localized to the outer mitochondrial membrane (OMM) and contains a cytosolic PDZ domain that functions as a cellular signaling hub .

SYNJ2BP antibodies are immunoglobulins specifically designed to recognize and bind to the SYNJ2BP protein or its specific domains. These antibodies have become essential tools in scientific research, particularly for studying mitochondrial function, cellular signaling, and protein-protein interactions involving SYNJ2BP . They enable researchers to detect, quantify, and localize SYNJ2BP in various experimental settings, contributing significantly to our understanding of its biological roles.

Recent studies have demonstrated that SYNJ2BP plays a crucial role in tethering mitochondria to the endoplasmic reticulum (ER) through interaction with an ER membrane binding partner called RRBP1, forming mitochondria-associated membranes (MAMs) . This finding has important implications for understanding cellular energetics, calcium homeostasis, and response to cellular stress.

Clonality Types

SYNJ2BP antibodies are available as both monoclonal and polyclonal variants:

  1. Monoclonal antibodies: These are derived from identical B cells and recognize a single epitope on the SYNJ2BP protein. For example, OTI3A9 is a mouse monoclonal antibody against SYNJ2BP available in PE/Cy5.5 conjugated form .

  2. Polyclonal antibodies: These are derived from different B cell lineages and can recognize multiple epitopes on the SYNJ2BP protein. Rabbit polyclonal antibodies targeting various regions of SYNJ2BP are commercially available .

Target Epitopes and Domains

SYNJ2BP antibodies target various amino acid sequences of the protein:

  1. AA 1-117 antibodies: These target the N-terminal region of SYNJ2BP .

  2. AA 1-145 antibodies: These have a broader epitope recognition at the N-terminal .

  3. AA 22-66 antibodies: These target a more specific internal sequence .

  4. N-terminal specific antibodies: These specifically recognize the N-terminal portion of the protein .

Host Species and Conjugations

SYNJ2BP antibodies are produced in different host species and are available with various conjugations:

Host SpeciesConjugation OptionsTarget EpitopesCatalog Examples
RabbitUnconjugated, HRP, Biotin, FITCAA 1-117, N-terminalABIN7171128, ab224217
MouseUnconjugated, PE/Cy5.5AA 1-145, Full lengthNBP2-74417PECY55, 3A9 clone

Conjugated antibodies are particularly useful for specific applications: HRP-conjugated for enhanced detection in ELISA and Western blotting, biotin-conjugated for amplification systems, and fluorophore-conjugated (FITC, PE/Cy5.5) for flow cytometry and immunofluorescence applications .

Applications and Methodologies

SYNJ2BP antibodies have diverse applications in both basic research and clinical investigations. Their utility spans multiple experimental techniques and methodologies.

Western Blotting

SYNJ2BP antibodies are widely used in Western blotting, with recommended dilutions typically ranging from 1:500 to 1:5000 . This technique allows for detection and semi-quantification of SYNJ2BP protein in cell and tissue lysates. Western blot analysis has been instrumental in demonstrating elevated SYNJ2BP protein levels in both SBMA and ALS4 patient-derived motor neurons .

Immunohistochemistry

For immunohistochemistry applications, SYNJ2BP antibodies are typically used at dilutions between 1:20 and 1:200 for paraffin-embedded tissues . Immunohistochemical staining has confirmed elevated SYNJ2BP in spinal motor neurons of SBMA patients . Some antibodies require heat-mediated antigen retrieval for optimal staining .

Immunofluorescence and Flow Cytometry

SYNJ2BP antibodies conjugated to fluorophores such as FITC or PE/Cy5.5 are particularly valuable for immunofluorescence and flow cytometry applications . The OTI3A9 monoclonal antibody conjugated to PE/Cy5.5, for example, is specifically validated for flow cytometry and can be used to assess SYNJ2BP expression levels in various cell types .

Proximity Ligation Assay

Proximity ligation assay (PLA) using antibodies against SYNJ2BP and other markers has been employed to quantify mitochondria-ER interactions. This technique permits detection of protein-protein interactions in situ at distances less than 40 nm, providing valuable insights into the spatial organization of mitochondria and ER in cells .

Immunoprecipitation

SYNJ2BP antibodies are also utilized for immunoprecipitation, with recommended dilutions ranging from 1:200 to 1:2000 . This application helps identify protein interaction partners of SYNJ2BP, contributing to our understanding of its functional networks.

Role of SYNJ2BP in Cellular Functions

Recent research has uncovered several important cellular functions of SYNJ2BP, which have been elucidated in part through the use of SYNJ2BP antibodies.

Mitochondria-ER Contact Formation

SYNJ2BP has been identified as a key protein enriched in mitochondria-associated membranes (MAMs) . It localizes to the outer mitochondrial membrane and can tether mitochondria to the ER through interaction with the ER membrane binding partner RRBP1. This tethering function is critical for the formation of MAMs, which serve as important signaling hubs for calcium transfer, lipid biosynthesis, and cellular stress responses .

ATP and Calcium Homeostasis

Research has demonstrated that SYNJ2BP-mediated MAM formation influences the levels of ATP and calcium ions available to the ER, which are essential factors for protein production . In SYNJ2BP knockout cells, the number of MAMs was significantly reduced, leading to lower ATP and calcium levels in the ER. This finding highlights SYNJ2BP's role in maintaining optimal conditions for protein synthesis and processing .

ER Stress Regulation

SYNJ2BP has been shown to reduce endoplasmic reticulum stress induced by viral proteins such as HIV or EIAV Envs . This function appears to be related to its ability to enhance MAM formation, which may improve ER function and protein folding capacity. By alleviating ER stress, SYNJ2BP can indirectly enhance the production of certain proteins, including viral envelope proteins .

SYNJ2BP in Disease Pathology

SYNJ2BP has been implicated in several disease contexts, with its dysregulation potentially contributing to pathological processes.

Motor Neuron Diseases

Studies using induced pluripotent stem cell (iPSC)-derived motor neurons from patients with hereditary motor neuron diseases have revealed altered SYNJ2BP expression. Specifically:

  1. Spinal and Bulbar Muscular Atrophy (SBMA): SYNJ2BP expression is significantly elevated in SBMA iPSC-derived motor neurons. This increased expression appears to be mediated by mutant androgen receptor (AR) with toxic gain of function .

  2. Amyotrophic Lateral Sclerosis Type 4 (ALS4): Increased SYNJ2BP protein levels have been observed in ALS4 patient-derived motor neurons, although without corresponding increases in mRNA levels, suggesting altered protein turnover rather than changes in gene expression .

Mitochondrial Dysfunction

Elevated SYNJ2BP has been associated with alterations in mitochondrial distribution and function. In SBMA iPSC-derived motor neurons, increased SYNJ2BP expression correlates with elevated mitochondrial stress and impaired mitochondrial function . This suggests that abnormal SYNJ2BP levels may contribute to the mitochondrial dysfunction observed in certain neurodegenerative diseases.

Viral Infection and Replication

SYNJ2BP has been found to play a role in viral replication, particularly for lentiviruses. Studies have shown that:

  1. SYNJ2BP transcript numbers increase during Equine Infectious Anemia Virus (EIAV) replication in host cells .

  2. Knockdown of SYNJ2BP leads to decreased EIAV replication efficiency .

  3. SYNJ2BP enhances the production of viral envelope proteins for both EIAV and HIV, potentially by providing optimal ER conditions through increased MAM formation .

Research Advancements and Recent Findings

Recent scientific investigations have expanded our understanding of SYNJ2BP function and potential applications of SYNJ2BP antibodies.

Enhancement of Lentiviral Envelope Protein Production

A significant discovery is that SYNJ2BP can improve the infectivity of lentiviruses by enhancing the production of viral envelope proteins . This effect appears to be specific to envelope proteins, as SYNJ2BP did not affect the production of other viral proteins such as Gag (the precursor of capsids p24 and p26) or the non-structural protein Rev .

The mechanism behind this enhancement involves SYNJ2BP-mediated increases in MAM formation, which provides more ATP and calcium ions to the ER while reducing ER stress induced by viral envelope proteins . This finding has potential implications for virology research and possibly for the development of viral vectors for gene therapy.

Cellular Response to Stress

Research has demonstrated that SYNJ2BP expression increases in iPSC-derived motor neurons undergoing stress . This suggests that SYNJ2BP upregulation may be part of a cellular stress response mechanism, potentially aimed at enhancing mitochondria-ER communication during challenging conditions.

Therapeutic Potential

Emerging research suggests potential therapeutic avenues involving SYNJ2BP:

  1. In motor neuron disease models, decreasing SYNJ2BP levels improves mitochondrial oxidative function in diseased motor neurons . This finding suggests that SYNJ2BP might be a target for therapeutic intervention in certain neurodegenerative diseases.

  2. The role of SYNJ2BP in viral envelope protein production suggests potential applications in optimizing viral vector production for gene therapy or in developing antiviral strategies .

Available Products and Their Characteristics

The following table summarizes key commercially available SYNJ2BP antibodies and their specifications:

Catalog NumberHostClonalityTarget RegionApplicationsReactivityConjugation
ABIN7171128RabbitPolyclonalAA 1-117WB, IHC, ELISA, IPHuman, RatUnconjugated
NBP2-74417PECY55MouseMonoclonal (OTI3A9)Full lengthFlow CytometryHuman, Mouse, RatPE/Cy5.5
ab224217RabbitPolyclonalN-terminalWB, IHC-P, ICC/IFHuman, MouseUnconjugated

Additional variants are available with different conjugations (HRP, Biotin, FITC) and target epitopes (AA 1-145, AA 22-66) .

Validation and Quality Control

Commercial SYNJ2BP antibodies undergo validation for specific applications:

  1. Western blot validation using cell lines such as RT4 and tissue lysates from human and mouse cerebral cortex .

  2. Immunohistochemistry validation using human tissues including prostate and duodenum .

  3. Flow cytometry validation for fluorophore-conjugated antibodies .

Product Specs

Buffer
PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. Stored at -20°C. Avoid freeze-thaw cycles.
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your order. Delivery times may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery times.
Synonyms
SYNJ2BP antibody; OMP25 antibody; Synaptojanin-2-binding protein antibody; Mitochondrial outer membrane protein 25 antibody
Target Names
SYNJ2BP
Uniprot No.

Target Background

Function
SYNJ2BP regulates the endocytosis of activin type 2 receptor kinases through the Ral/RALBP1-dependent pathway and may play a role in suppressing activin-induced signal transduction.
Gene References Into Functions
  1. Studies have demonstrated that SYNJ2BP expression is reduced in hepatocellular carcinoma (HCC) tissues and cell lines, suggesting that it may act as a tumor suppressor in HCC development by activating the DLL4 pathway. PMID: 27440153
  2. Ubiquilins are a family of chaperones responsible for the trafficking of cytosolically exposed transmembrane domains. They utilize ubiquitin to target clients, such as Omp25, for degradation through coordinated intra- and intermolecular interactions. PMID: 27345149
  3. Research findings indicate that ARIP2 is a potential growth-promoting factor involved in breast tumorigenesis and tumor development. PMID: 19349195
Database Links

HGNC: 18955

OMIM: 609411

KEGG: hsa:55333

STRING: 9606.ENSP00000256366

UniGene: Hs.443661

Subcellular Location
Mitochondrion outer membrane.

Q&A

What is SYNJ2BP and what is its biological significance?

SYNJ2BP is an outer mitochondrial membrane protein with a cytosolic PDZ domain that functions as a cellular signaling hub. While its normal physiological role is still being investigated, recent studies show that SYNJ2BP plays a crucial role in regulating mitochondrial-ER membrane contact sites (MERC). SYNJ2BP has gained significant interest due to its increased expression in motor neuron diseases, including spinal and bulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis type 4 (ALS4) . The protein appears to respond to cellular stress conditions, as evidenced by its upregulation following hydrogen peroxide treatment in induced pluripotent stem cell-derived motor neurons (iMNs) .

What are the molecular characteristics of SYNJ2BP protein?

SYNJ2BP is a relatively small protein with 145 amino acids and a calculated molecular weight of 16 kDa, which corresponds to its observed molecular weight in experimental settings . The protein is encoded by the SYNJ2BP gene (ID: 55333) and has the UniProt ID P57105 . In subcellular localization studies, SYNJ2BP has been confirmed to colocalize with mitochondria in spinal motor neurons through immunofluorescence staining . Its structure includes a PDZ domain in the cytosolic region, which facilitates protein-protein interactions that are crucial for its signaling functions.

What species reactivity has been confirmed for SYNJ2BP antibodies?

Commercial SYNJ2BP antibodies have demonstrated reactivity with samples from multiple species. According to validation data, SYNJ2BP antibodies have been tested and confirmed to work with human, mouse, and rat samples . Specifically, Western blot applications have successfully detected SYNJ2BP in mouse kidney tissue, mouse lung tissue, rat kidney tissue, and human cell lines such as A549 . Immunohistochemistry has been validated on human tissue samples, and immunofluorescence applications have been confirmed in human cell lines including HepG2 and MCF-7 .

What are the optimal dilutions for different applications of SYNJ2BP antibody?

The recommended dilutions for SYNJ2BP antibody vary depending on the specific application. Based on validated protocols, the following dilutions are recommended:

ApplicationRecommended Dilution
Western Blot (WB)1:500-1:2000
Immunoprecipitation (IP)0.5-4.0 μg for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)1:20-1:200
Immunofluorescence (IF)/ICC1:200-1:800
Flow Cytometry (FC) (Intracellular)0.40 μg per 10^6 cells in 100 μl suspension

It is important to note that these are general recommendations, and the optimal dilution should be determined empirically for each experimental system and sample type . Titration experiments are recommended to establish the optimal antibody concentration that maximizes specific signal while minimizing background.

How should samples be prepared for Western blot detection of SYNJ2BP?

For optimal Western blot detection of SYNJ2BP, sample preparation should include careful lysis and protein extraction methods that preserve mitochondrial proteins. Since SYNJ2BP is a mitochondrial membrane protein, standard protocols for membrane protein extraction are recommended.

Based on published research, the following method has proven effective: Use a lysis buffer containing 1% Triton X-100 or NP-40, protease inhibitors, and phosphatase inhibitors. Homogenize tissue samples thoroughly or lyse cells directly in the buffer. Clarify lysates by centrifugation at 14,000g for 10 minutes at 4°C. For protein separation, use 12-15% SDS-PAGE gels which are optimal for resolving proteins in the 16 kDa range .

When transferring to membranes, PVDF membranes may provide better retention of small proteins compared to nitrocellulose. After transfer, block with 5% non-fat dry milk or BSA in TBST. The antibody can then be applied at the recommended dilution (1:500-1:2000) and incubated overnight at 4°C for optimal results .

What controls should be used when studying SYNJ2BP expression?

When studying SYNJ2BP expression, several controls should be implemented to ensure experimental validity:

  • Positive controls: Use samples known to express SYNJ2BP, such as mouse kidney tissue, mouse lung tissue, or A549 cells, which have been validated to express detectable levels of SYNJ2BP .

  • Negative controls: Include samples where SYNJ2BP expression has been knocked down or knocked out. This approach has been validated in published literature .

  • Loading controls: For Western blots, include housekeeping proteins such as GAPDH, β-actin, or mitochondrial markers like VDAC for normalization.

  • Antibody controls: Include a no-primary antibody control and an isotype control (rabbit IgG for polyclonal antibodies) to assess non-specific binding .

  • Specificity controls: When possible, use competitive blocking with the immunizing peptide to confirm antibody specificity.

In the context of motor neuron studies, normalizing SYNJ2BP expression to motor neuron markers like choline acetyltransferase (ChAT) can be particularly important when analyzing tissues with variable motor neuron content, as demonstrated in studies of SBMA and ALS4 patient samples .

How does SYNJ2BP contribute to mitochondrial-ER contacts in neurons?

SYNJ2BP plays a critical role in establishing and maintaining mitochondrial-ER membrane contact sites (MERC) in neurons. Proteomic analysis of SYNJ2BP interactors revealed enrichment of ER-related proteins, suggesting its function in mitochondria-ER tethering . Transmission electron microscopy studies have provided direct evidence that overexpression of SYNJ2BP significantly increases mitochondria-ER contacts, defined as regions with <30 nm spacing between the two membranes .

The functional significance of this interaction has been demonstrated in both experimental overexpression systems and disease models. In SBMA-derived induced pluripotent stem cell motor neurons (iMNs), which naturally express higher levels of SYNJ2BP, the percentage of mitochondrial surface in contact with ER was significantly elevated compared to controls . This increased MERC formation correlates with altered mitochondrial distribution, with mitochondria showing perinuclear clustering in the soma and reduced presence in neurites .

Mechanistically, SYNJ2BP appears to interact with specific ER membrane proteins through its PDZ domain, creating a physical tether between mitochondria and ER. This tethering facilitates calcium signaling, lipid transfer, and possibly other functions between these organelles, which are crucial for neuronal homeostasis.

What is the relationship between SYNJ2BP expression and motor neuron diseases?

Research has established a significant correlation between elevated SYNJ2BP expression and motor neuron diseases. Studies of patient-derived iMNs and post-mortem tissue from individuals with SBMA and ALS4 have consistently shown increased SYNJ2BP levels compared to healthy controls .

In SBMA, the mechanism of SYNJ2BP upregulation appears to involve mutant androgen receptor (AR) with polyglutamine expansion. ChIP-seq analysis has revealed binding of mutant AR to a non-canonical site near the SYNJ2BP gene promoter, potentially enhancing its transcription . Supporting this mechanism, knockout of AR in both control and SBMA iMNs reduced SYNJ2BP expression, suggesting that SYNJ2BP might be a target of wild-type AR with enhanced transcriptional activity due to polyQ expansion .

In ALS4, which is caused by dominant mutations in senataxin (SETX), SYNJ2BP protein levels were also elevated despite unchanged mRNA levels, suggesting post-transcriptional regulation such as altered protein turnover .

Additionally, SYNJ2BP expression increases acutely in response to oxidative stress. Treatment of healthy motor neurons with hydrogen peroxide led to rapid upregulation of SYNJ2BP within two hours, indicating that SYNJ2BP upregulation may be a general response to cellular stress in motor neurons .

How can researchers quantify changes in MERC following manipulation of SYNJ2BP levels?

Quantifying changes in mitochondrial-ER membrane contact sites (MERC) following SYNJ2BP manipulation requires specialized techniques. Based on published methodologies, researchers can employ several approaches:

  • Transmission Electron Microscopy (TEM): This high-resolution imaging technique allows direct visualization of contacts between mitochondria and ER membranes. MERC can be quantified as regions where the spacing between mitochondrial and ER membranes is <30 nm . Analysis should include:

    • Percentage of mitochondrial surface in contact with ER

    • Average length of contact sites

    • Number of contact sites per mitochondrion

  • Proximity Ligation Assay (PLA): This technique detects protein-protein interactions within a 40 nm distance. For MERC quantification, researchers can target SYNJ2BP and ER proteins like RRBP1, or other established MERC components like VDAC1 and IP3R . PLA signals appear as fluorescent dots that can be counted to quantify interaction frequency.

  • Fluorescence Microscopy with Organelle Markers: Co-localization analysis of fluorescently labeled mitochondria and ER can provide quantitative measures of their proximity.

  • Mitochondrial Distribution Analysis: SYNJ2BP overexpression alters mitochondrial distribution in neurons. Researchers can employ automated analysis methods such as Mahalanobis distance measurement to quantify mitochondrial distribution in an unbiased manner that does not assume circular cell shape .

When manipulating SYNJ2BP levels through overexpression or knockdown approaches, appropriate controls should be included to ensure that observed changes in MERC are specifically due to altered SYNJ2BP levels rather than experimental artifacts.

Why might non-specific bands appear when detecting SYNJ2BP by Western blot?

Non-specific bands when detecting SYNJ2BP by Western blot can arise from several factors. SYNJ2BP has a relatively small molecular weight (16 kDa), which can present challenges in distinguishing specific signals from background. Common sources of non-specific bands include:

  • Cross-reactivity with related proteins: SYNJ2BP shares some sequence homology with other PDZ domain-containing proteins, which might be recognized by polyclonal antibodies.

  • Sample preparation issues: Incomplete denaturation or protein degradation can result in additional bands. Ensure complete sample denaturation by heating at 95°C for 5 minutes in SDS sample buffer and include protease inhibitors during sample preparation.

  • Antibody concentration: Excessive antibody concentration can increase non-specific binding. Titrate antibody dilutions (1:500-1:2000) to find the optimal concentration that maximizes specific signal while minimizing background .

  • Blocking conditions: Inadequate blocking can lead to non-specific binding. Consider using 5% BSA instead of milk for blocking when detecting phosphorylated forms of proteins or membrane proteins like SYNJ2BP.

  • Secondary antibody issues: Ensure secondary antibodies are highly cross-adsorbed to minimize species cross-reactivity.

To confirm band specificity, researchers should consider including a SYNJ2BP knockdown or knockout sample as a negative control, as this approach has been validated in published studies .

How can I optimize antigen retrieval for SYNJ2BP immunohistochemistry?

Optimizing antigen retrieval for SYNJ2BP immunohistochemistry is crucial for specific and sensitive detection. Based on validated protocols, the following optimization strategies are recommended:

  • Buffer selection: Compare TE buffer (pH 9.0) and citrate buffer (pH 6.0) to determine which provides optimal staining for your specific tissue.

  • Heating method: Test different heating methods including microwave, pressure cooker, or water bath. Pressure cookers often provide consistent results for SYNJ2BP detection.

  • Heating time: Optimize the duration of heat treatment, typically testing ranges from 10-30 minutes.

  • Cooling period: Allow slides to cool slowly to room temperature (20-30 minutes) before proceeding with immunostaining.

  • Antibody dilution: For SYNJ2BP immunohistochemistry, test dilutions within the recommended range of 1:20-1:200 .

  • Incubation conditions: Optimize primary antibody incubation time (overnight at 4°C versus 1-2 hours at room temperature) and temperature.

For tissue-specific optimization, it's worth noting that successful SYNJ2BP immunohistochemistry has been reported in human stomach cancer tissue and spinal cord sections from motor neuron disease patients . When working with neuronal tissues specifically, additional permeabilization steps may improve antibody penetration.

How can SYNJ2BP antibodies be used to study mitochondrial dysfunction in neurodegenerative diseases?

SYNJ2BP antibodies offer valuable tools for investigating mitochondrial dysfunction in neurodegenerative diseases, particularly those affecting motor neurons. Several methodological approaches have proven effective:

  • Expression analysis: SYNJ2BP antibodies can be used to quantify protein levels in patient-derived samples (iPSC-derived neurons, post-mortem tissues) using Western blot, immunohistochemistry, or immunofluorescence. This approach has successfully demonstrated elevated SYNJ2BP levels in both SBMA and ALS4 patient samples .

  • Subcellular localization studies: Immunofluorescence co-localization of SYNJ2BP with mitochondrial markers can reveal alterations in mitochondrial distribution. This approach has shown that increased SYNJ2BP levels correlate with perinuclear clustering of mitochondria in motor neurons .

  • Protein-protein interaction analysis: Co-immunoprecipitation (Co-IP) combined with mass spectrometry has identified SYNJ2BP interactions with ER-related proteins . Researchers can use SYNJ2BP antibodies for Co-IP to identify novel interaction partners in disease contexts.

  • Proximity ligation assay (PLA): SYNJ2BP antibodies can be employed in PLA to quantify interactions with other proteins in situ. This technique has successfully demonstrated increased MERC in patient spinal motor neurons by assessing SYNJ2BP proximity with RRBP1 .

  • Therapeutic target validation: Following the finding that reducing SYNJ2BP expression improves mitochondrial oxidative function in patient cells , SYNJ2BP antibodies can be used to validate and monitor the effects of therapeutic interventions targeting this pathway.

Future research directions could explore the use of SYNJ2BP antibodies in live-cell imaging techniques or in combination with super-resolution microscopy to further elucidate the dynamics of mitochondrial-ER contacts in real-time during disease progression.

What are the emerging roles of SYNJ2BP beyond mitochondrial-ER contacts?

While SYNJ2BP's role in mitochondrial-ER contacts is well-established, emerging research suggests broader functions that may be relevant to neurobiology and disease. These include:

  • Cellular stress response: SYNJ2BP expression increases rapidly (within two hours) in response to oxidative stress induced by hydrogen peroxide, suggesting a role in acute stress response pathways . This rapid upregulation indicates that SYNJ2BP may serve as an early responder to cellular stress conditions.

  • Transcriptional regulation: The finding that mutant androgen receptor binds near the SYNJ2BP gene promoter suggests potential involvement in transcriptional regulatory networks . This binding occurs at a non-canonical site enriched for Iroquois homeobox (IRX) transcription factor family binding motifs, which typically function as transcriptional repressors .

  • Mitochondrial distribution and transport: Beyond its role in MERC, SYNJ2BP significantly impacts mitochondrial distribution in neurons, with overexpression reducing mitochondrial presence in axons . This suggests potential involvement in mitochondrial transport mechanisms, which are crucial for neuronal function.

  • PDZ domain interactions: As a PDZ domain-containing protein, SYNJ2BP likely interacts with multiple partners through this protein-protein interaction module. Comprehensive mapping of these interactions in different cellular contexts may reveal additional functions.

Further investigation of these emerging roles could be facilitated by combining SYNJ2BP antibody-based detection methods with techniques like ChIP-seq, RNA-seq, and live cell imaging of mitochondrial dynamics. Understanding these broader functions may reveal new therapeutic opportunities for neurodegenerative conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.